Expert Review of Vaccines

Pandemic influenza vaccine development: time is of the essence
pp. 603-606(4)
Authors: Cox, Rebecca J; Brokstad, Karl A; Haaheim, Lars R

Current vaccine-producing capacity can accommodate an influenza pandemic in the USA
pp. 607-608(2)

Vaccine patch for influenza enters Phase I clinical trial
pp. 609-609(1)

RTS,S/AS02A for malaria
pp. 611-615(5)
Author: Bojang, Kalifa A

Pollinex^® Quattro: a novel and well-tolerated, ultra short-course allergy vaccine
pp. 617-629(13)
Authors: Patel, Piyush; Salapatek, Anne Marie F

Do vaccines modify the prevalence of asthma and allergies?
pp. 631-640(10)
Authors: Sánchez-Solis, Manuel; García-Marcos, Luis

Postlicensure epidemiology of childhood vaccination: the Danish experience
pp. 641-649(9)
Author: Hviid, Anders

Nasopharyngeal colonization: a target for pneumococcal vaccination
pp. 651-667(17)
Authors: Käyhty, Helena; Auranen, Kari; Nohynek, Hanna; Dagan, Ron; Mäkelä, Helena

Live-attenuated Shigella vaccines
pp. 669-686(18)
Authors: Venkatesan, Malabi M; Ranallo, Ryan T

Towards a universal group B Streptococcus vaccine using multistrain genome analysis
pp. 687-694(8)
Authors: Tettelin, Hervé; Medini, Duccio; Donati, Claudio; Masignani, Vega

Live vaccines for human metapneumovirus designed by reverse genetics
pp. 695-706(12)
Authors: Buchholz, Ursula J; Nagashima, Kunio; Murphy, Brian R; Collins, Peter L

Therapeutic vaccination in chronic hepatitis B virus carriers
pp. 707-716(10)
Authors: Pol, Stanislas; Michel, Marie-Louise

Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials
pp. 717-732(16)
Authors: Mossoba, Miriam E; Medin, Jeffrey A